NKY Medical Holdings (SZSE:300109) Net Income From Continuing Operations : ¥487 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. NKY Medical Holdings's net income from continuing operations for the three months ended in Mar. 2024 was ¥121 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥487 Mil.

NKY Medical Holdings Net Income From Continuing Operations Historical Data

The historical data trend for NKY Medical Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Net Income From Continuing Operations Chart

NKY Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

125.75

32.64

194.82

281.43

485.79

NKY Medical Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															119.31	140.00	142.34	84.13	120.93

NKY Medical Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥487 Mil.

NKY Medical Holdings (SZSE:300109) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450

Website

http://www.boai-nky.com

NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

Executives

Zhang Jun Zheng	Directors, executives
Yang Hong Bo	Director
Wang Dong Hu	Director
Ren Da Long	Director
Xing Xiao Liang	Directors, executives
Zou Xiao Wen	Executives
Wang Shi Gang	Executives
Wang Xin Meng	Executives
Qu Yun Xia	Supervisors
Wang Jian Qiang	Director
Yang Hai Jiang	Director
Yan Zhong Chao	Supervisors
Liu Ai Min	Executives
Wu Cong Zhou	Executives
Wu Wen Bin	Director

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines